Target
Cytochrome P450 3A4
Ligand
BDBM50001533
Substrate
n/a
Meas. Tech.
ChEMBL_1336037 (CHEMBL3240531)
IC50
>10000±n/a nM
Citation
 Li, ZWang, XEksterowicz, JGribble, MWAlba, GQAyres, MCarlson, TJChen, AChen, XCho, RConnors, RVDeGraffenreid, MDeignan, JTDuquette, JFan, PFisher, BFu, JHuard, JNKaizerman, JKeegan, KSLi, CLi, KLi, YLiang, LLiu, WLively, SELo, MCMa, JMcMinn, DLMihalic, JTModi, KNgo, RPattabiraman, KPiper, DEQueva, CRagains, MLSuchomel, JThibault, SWalker, NWang, XWang, ZWanska, MWehn, PMWeidner, MFZhang, AJZhao, XKamb, AWickramasinghe, DDai, KMcGee, LRMedina, JC Discovery of AMG 925, a FLT3 and CDK4 dual kinase inhibitor with preferential affinity for the activated state of FLT3. J Med Chem 57:3430-49 (2014) [PubMed]  Article 
Target
Name:
Cytochrome P450 3A4
Synonyms:
Albendazole monooxygenase | Albendazole sulfoxidase | CP3A4_HUMAN | CYP3A3 | CYP3A4 | CYPIIIA3 | CYPIIIA4 | Cytochrome P450 3A3 | Cytochrome P450 3A4 (CYP3A4) | Cytochrome P450 HLp | Nifedipine oxidase | Quinine 3-monooxygenase | Taurochenodeoxycholate 6-alpha-hydroxylase
Type:
Enzyme
Mol. Mass.:
57349.57
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
503
Sequence:
MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGA
  
Inhibitor
Name:
BDBM50001533
Synonyms:
CHEMBL3237448 | US8841312, 200
Type:
Small organic molecule
Emp. Form.:
C22H25N9
Mol. Mass.:
415.4942
SMILES:
C1CCC(C1)n1c2nnccc2c2cnc(Nc3ccc(cn3)N3CCNCC3)nc12
Structure:
Search PDB for entries with ligand similarity: